These were, HMMR, PFKP, RRM2, TCN1 and TK1. By comparing their expression levels and their association with immune cells in pan-cancer and lung cancer clinical samples, we identified a critical role for RRM2 in LUAD. Here, PFKP is linked to lung cancer.